关注
Spoorthy Kulkarni
Spoorthy Kulkarni
在 cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
COVID-19 and hypertension
S Kulkarni, BL Jenner, I Wilkinson
Journal of the renin-angiotensin-aldosterone system 21 (2), 1470320320927851, 2020
812020
Niclosamide—a promising treatment for COVID‐19
S Singh, A Weiss, J Goodman, M Fisk, S Kulkarni, I Lu, J Gray, R Smith, ...
British journal of pharmacology 179 (13), 3250-3267, 2022
462022
Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: a retrospective study
S Kulkarni, R Rao, JDH Goodman, K Connolly, KM O'Shaughnessy
Medicine 100 (14), e24654, 2021
392021
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients-mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19–Repurposed Drugs (TACTIC-R): A …
S Kulkarni, M Fisk, M Kostapanos, E Banham-Hall, S Bond, ...
Trials 21, 1-3, 2020
332020
Hepatic pathology in AIDS: a pathological study from Mumbai, India
DN Lanjewar, RJ Rao, SB Kulkarni, SK Hira
HIV medicine 5 (4), 253-257, 2004
252004
Hypertension management in 2030: a kaleidoscopic view
S Kulkarni
Journal of Human Hypertension 35 (9), 812-817, 2021
192021
Management of hypertensive crisis: British and Irish Hypertension Society Position document
S Kulkarni, M Glover, V Kapil, SML Abrams, S Partridge, T McCormack, ...
Journal of human hypertension 37 (10), 863-879, 2023
172023
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized …
IN Lu, S Kulkarni, M Fisk, M Kostapanos, E Banham-Hall, S Kadyan, ...
Trials 21, 1-3, 2020
162020
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
H Pavey, S Kulkarni, A Wood, Y Ben-Shlomo, P Sever, C McEniery, ...
PLoS One 17 (11), e0276781, 2022
82022
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society
L Faconti, S Kulkarni, C Delles, V Kapil, P Lewis, M Glover, ...
Journal of Human Hypertension 38 (1), 8-18, 2024
72024
Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis
S Kulkarni, H Durham, L Glover, O Ather, V Phillips, S Nemes, L Cousens, ...
BMJ open 12 (12), e061476, 2022
62022
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial
FC Hall, J Cheriyan, AP Cope, J Galloway, I Wilkinson, S Bond, S Norton, ...
The Lancet Respiratory Medicine 11 (12), 1064-1074, 2023
52023
Research and development of low cost processes for integrated solar arrays
CD Graham, S Kulkarni, E Louis
NASA STI/Recon Technical Report N 77, 26670, 1976
51976
Sustainable medicines use in clinical practice: a clinical pharmacological view on eco‐pharmaco‐stewardship
E Adeyeye, BJM New, F Chen, S Kulkarni, M Fisk, JJ Coleman
British journal of clinical pharmacology 88 (7), 3023-3029, 2022
42022
Two Cases of Severe Hypertension in JAK2 Mutation‐Positive Myeloproliferative Neoplasms
R Rao, S Kulkarni, IB Wilkinson
Case reports in vascular medicine 2020 (1), 8887423, 2020
32020
Quo vadis (where are you going) pharmacovigilance?
S Kulkarni, M Rieder, R Likic
British journal of clinical pharmacology 89 (2), 2023
22023
CONNed in pregnancy
S Kulkarni, AF Dominiczak, RM Touyz, JD Spence, D Batlle, M Barigou, ...
Hypertension 78 (1), 241-249, 2021
22021
1.5 Age and Sex Differences in the Association of Brachial and Central Blood Pressure Variability with Arterial Stiffness
S Yu, K Connolly, S Kulkarni, V Selvarajah, J Woodcock-Smith, ...
Artery Research 25 (Suppl 1), S4-S5, 2019
12019
Investigation and management of young-onset hypertension: British and Irish hypertension society position statement
S Kulkarni, L Faconti, S Partridge, C Delles, M Glover, P Lewis, A Gray, ...
Journal of Human Hypertension, 1-11, 2024
2024
Adrenoceptors and Hypertension
S Kulkarni, IB Wilkinson
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20